Evaluation of commercially available low molecular mass heparin products: an internal market surveillance study

Ina Baručija, Amar Elezović, Alija Uzunović, Sabina Bešlagić, Dženita Softić

Open source

DOI: 10.33320/maced.pharm.bull.2026.72.03.160
Published: 10
Container: Makedonsko Farmacevtski Bilten
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.33320/maced.pharm.bull.2026.72.03.160,
  title = {Evaluation of commercially available low molecular mass heparin products: an internal market surveillance study},
  author = {Ina Baručija and Amar Elezović and Alija Uzunović and Sabina Bešlagić and Dženita Softić},
  year = {2026},
  journal = {Makedonsko Farmacevtski Bilten},
  doi = {10.33320/maced.pharm.bull.2026.72.03.160},
  url = {https://doi.org/10.33320/maced.pharm.bull.2026.72.03.160}
}

RIS

TY  - JOUR
TI  - Evaluation of commercially available low molecular mass heparin products: an internal market surveillance study
AU  - Ina Baručija
AU  - Amar Elezović
AU  - Alija Uzunović
AU  - Sabina Bešlagić
AU  - Dženita Softić
PY  - 2026
JO  - Makedonsko Farmacevtski Bilten
DO  - 10.33320/maced.pharm.bull.2026.72.03.160
UR  - https://doi.org/10.33320/maced.pharm.bull.2026.72.03.160
ER  -

APA

Baručija, I., Elezović, A., Uzunović, A., Bešlagić, S., & Softić, D. (2026). Evaluation of commercially available low molecular mass heparin products: an internal market surveillance study. Makedonsko Farmacevtski Bilten. https://doi.org/10.33320/maced.pharm.bull.2026.72.03.160

Source records

doaj · retrieved 2026-09-26T04:05:55.128Z